HDAC/aromatase inhibitor combo shows promise for HR+/HER2- advanced breast cancerOctober 21, 2018Breast Cancer
Genotype-driven dosing reduces 5-FU, capecitabine toxicityOctober 20, 2018GastroenterologyBreast CancerGastrointestinal Cancer
Tech-based cancer company raises access concernsOctober 12, 2018Practice ManagementPatient & Survivor CareBreast CancerGynecologic Cancer
MBC care causes more money problems for uninsured – but more financial stress for the insuredOctober 4, 2018Breast CancerPatient & Survivor CarePractice Management
Breast cancer risk in type 2 diabetes related to adiposityOctober 1, 2018Breast CancerPreventive Care
Breast cancer patients getting unnecessary scans against recommendationsSeptember 28, 2018Breast CancerPatient & Survivor Care
Metastatic breast cancer lesions immunologically depleted compared with primarySeptember 17, 2018Breast CancerMetastatic Breast Cancer
Outcomes similar for concurrent versus sequential treatment in HER2-positive breast cancersSeptember 10, 2018Breast Cancer
Top cancer researcher fails to disclose corporate financial ties in major research journalsSeptember 10, 2018Breast Cancer
